Show simple item record

dc.contributor.authorAmerson, Erin
dc.contributor.authorBuziba, Nathan
dc.contributor.authorWabinga, Henry
dc.contributor.authorWenger, Megan
dc.contributor.authorBwana, Mwebesa
dc.contributor.authorMuyindike, Winnie
dc.contributor.authorKyakwera, Catherine
dc.contributor.authorLaker, Miriam
dc.contributor.authorMbidde, Edward
dc.contributor.authorYiannoutsos, Constantin
dc.contributor.authorWools-Kaloustian, Kara
dc.contributor.authorMusick, Beverly
dc.contributor.authorLeBoit, Philip
dc.contributor.authorMcCalmont, Tim
dc.contributor.authorRuben, Beth
dc.contributor.authorVolberding, Paul
dc.contributor.authorMaurer, Toby
dc.contributor.authorMartin, Jeffrey
dc.date.accessioned2024-03-21T09:46:08Z
dc.date.available2024-03-21T09:46:08Z
dc.date.issued2012
dc.identifier.citationAmerson, E., Buziba, N., Wabinga, H., Wenger, M., Bwana, M., Muyindike, W., ... & Martin, J. (2012). Diagnosing Kaposi’s Sarcoma (KS) in East Africa: how accurate are clinicians and pathologists?. Infectious Agents and Cancer, 7, 1-2.en_US
dc.identifier.urihttp://ir.must.ac.ug/xmlui/handle/123456789/3485
dc.description.abstractHIV-associated KS is the most common reported malignancy in sub-Saharan Africa, and appropriate therapy of KS requires accurate diagnosis. In much of the region, however, KS diagnosis is limited to clinical suspicion without pathologic confirmation. Where pathology is available, specific anti-KSHV stains are rarely available and overall pathologic accuracy for KS has not been evaluated.en_US
dc.language.isoen_USen_US
dc.publisherInfectious Agents and Canceren_US
dc.subjectHIVen_US
dc.subjectKaposi’s Sarcomaen_US
dc.subjectDiagnosisen_US
dc.subjectClinicians and pathologistsen_US
dc.titleDiagnosing Kaposi’s Sarcoma (KS) in East Africa: how accurate are clinicians and pathologists?en_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record